Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BIIB
#440
Biogen Inc. - Common Stock
218.5
0
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.35%
Monthly Change
+6.91%
6 month change
+15.60%
Year Change
+63.61%
Previous Close
221.5
0
Open
218.4
7
Low
218.4
7
High
218.5
0
Volume
123
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
BIIB
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
152.34 M
146.96 M
144.49 M
145.36 M
146.37 M
146.76 M
147.75 M
Valuation ratios
Enterprise value
44.16 B
42.26 B
43.1 B
45.24 B
27.01 B
29.88 B
32.08 B
Price to earnings ratio
9.87
23.07
13.06
33.59
13.68
20.02
39.25
Price to sales ratio
2.94
3.27
3.91
3.96
2.31
2.62
—
Price to cash flow ratio
9.34
9.86
28.75
25.19
7.76
11.74
10.76
Price to book ratio
3.69
3.29
2.97
2.63
-9.82
-11.28
—
Enterprise value to EBITDA ratio
8.82
12.7
10.49
25.25
10.47
12.79
—
Profitability ratios
Return on assets %
0.16
0.07
0.12
0.04
0.06
0.04
0
Return on equity %
0.37
0.14
0.23
0.08
0.1
0.07
0.01
Return on invested capital %
65.61
52.93
167.59
115.26
97.87
20.1
2.6
Gross margin %
86.57
80.79
77.61
74.24
76.12
75.69
71.6
Operating margin %
33.84
25.87
35.31
13.18
19.7
15.74
9.5
EBITDA margin %
37.24
30.31
40.4
18.22
26.66
23.62
18.46
Net margin %
29.76
14.17
29.95
11.81
16.87
13.07
3.56
Liquidity ratios
Quick ratio
1.55
1.51
2.58
1.26
0.9
2.03
1.26
Current ratio
1.84
1.83
2.99
2
1.35
2.68
1.87
Inventory turnover
1.93
1.74
1.69
1.31
0.93
1.11
0.33
Asset turnover
0.52
0.45
0.42
0.38
0.35
0.34
0.09
Solvency ratios
Debt to assets ratio
0.3
0.36
0.27
0.26
0.22
0.21
—
Debt to equity ratio
0.7
0.79
0.49
0.47
-2.47
-2.74
—
Long term debt to total assets ratio
0.3
0.26
0.26
0.26
0.22
0.21
0.23
Long term debt to total equity ratio
0.69
0.58
0.47
0.47
-2.47
-2.74
0.38
Per share metrics
Operating cash flow per share
26.22
24.33
9.48
10.63
19.71
14.99
20.55
EBIT per share
28.21
18.99
24.6
8.91
13.06
10.58
6.84
EBITDA per share
31.04
22.25
28.15
12.3
17.68
15.88
13.46
Total debt per share
46.5
57.26
44.98
47.65
43.15
42.74
—
Cash per share
11.82
28.22
35.02
7.06
12.64
21.47
5.07
Net current asset value per share
42.7
52.52
67.06
47.11
51.11
61.01
49.16
Tangible book value per share
66.34
72.84
91.77
101.64
-128.27
-122.13
-9.45
Working capital per share
19.5
23.79
44.65
23.52
13.21
38.24
22.8
Book value per share
66.34
72.84
91.77
101.64
-17.44
-15.61
128.56
News
Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
Acadia Pharmaceuticals: Another Bite At The Alzheimer's Apple (NASDAQ:ACAD)
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors (NASDAQ:TGTX)
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
Is Wall Street Bullish or Bearish on Biogen Stock?
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum
Biogen Stock: How To Find & Own America's Greatest Opportunities
IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook